Back to Market Feed

Product Information

INVEGA TRINZA 273 MG/0.88 ML is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $3950.9489 per ML under NDC 50458060601. Its NADAC has been published 96 times since Oct 23, 2024.

FDA first approved this application on May 18, 2015.

INVEGA TRINZA 273 MG/0.88 ML

paliperidone palmitate
$3950.9489per ML

Strength

273 mg/.88mL

NDC

50458060601

Classification

Brand

Dosage Form

INJECTION, SUSPENSION, EXTENDED RELEASE

Route

INTRAMUSCULAR

Effective Date

8/19/2026

Active Ingredients

PALIPERIDONE PALMITATE

Approval Type

New Drug (NDA)

FDA Application

NDA207946

FDA Approved

5/18/2015

On Market Since

5/19/2015

Pharmacological Classes

Atypical Antipsychotic

Price Statistics

The NADAC for INVEGA TRINZA 273 MG/0.88 ML has been published 96 times since Oct 23, 2024, and over the history we have for it it has risen 3.6%. The table below summarizes its recorded NADAC range and movement.

Current price$3950.9489 per ML
All-time high$3988.8369 (Jul 15, 2026)
All-time low$3807.1364 (Dec 18, 2024)
52-week high$3988.8369
52-week low$3882.7121
Median price$3906.1219
Average price$3915.3179
Largest weekly change+2.6% (Jan 15, 2025)
Weeks tracked96
Tracking sinceOct 23, 2024

Price History

1W

+0.4%

1M

+0.4%

3M

-0.9%

6M

-0.9%

1Y

+1.8%

3Y

N/A

5Y

N/A

All

+3.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the paliperidone palmitate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

SEROQUEL 25 MG TABLET
Brand
00310027510•AstraZeneca Pharmaceuticals LP
$3.7108
per EA
RISPERDAL 0.5 MG TABLET
Brand
50458030201•Janssen Pharmaceuticals Inc.
$4.3842
per EA
RISPERDAL 0.5 MG TABLET
Brand
50458030206•Janssen Pharmaceuticals Inc.
$4.3842
per EA
RISPERDAL 1 MG TABLET
Brand
50458030001•Janssen Pharmaceuticals Inc.
$4.6907
per EA
RISPERDAL 1 MG TABLET
Brand
50458030006•Janssen Pharmaceuticals Inc.
$4.6907
per EA
RISPERDAL 1 MG/ML SOLUTION
Brand
50458030503•Janssen Pharmaceuticals Inc.
$5.2820
per ML
SEROQUEL 50 MG TABLET
Brand
00310027810•AstraZeneca Pharmaceuticals LP
$6.0917
per EA
SEROQUEL 100 MG TABLET
Brand
00310027110•AstraZeneca Pharmaceuticals LP
$6.3807
per EA
CLOZARIL 25 MG TABLET
Brand
69809012605•HLS Therapeutics (USA), Inc.
$6.5446
per EA
SEROQUEL XR 50 MG TABLET
Brand
00310028060•AstraZeneca Pharmaceuticals LP
$7.7675
per EA

Frequently asked questions

What is the NADAC price of INVEGA TRINZA 273 MG/0.88 ML?

The current National Average Drug Acquisition Cost (NADAC) for INVEGA TRINZA 273 MG/0.88 ML, manufactured by Janssen Pharmaceuticals Inc., is $3950.9489 per ML (NDC 50458060601), effective Aug 19, 2026.

How has the price of INVEGA TRINZA 273 MG/0.88 ML changed over time?

Over the history we have for it, the NADAC for INVEGA TRINZA 273 MG/0.88 ML has risen 3.6%. It has been tracked across 96 weekly CMS publications since Oct 23, 2024.

What are the highest and lowest recorded NADAC prices for INVEGA TRINZA 273 MG/0.88 ML?

Since Oct 23, 2024, the NADAC for INVEGA TRINZA 273 MG/0.88 ML has ranged from a low of $3807.1364 (Dec 18, 2024) to a high of $3988.8369 (Jul 15, 2026), with a median of $3906.1219 per ML.

Are there cheaper alternatives to INVEGA TRINZA 273 MG/0.88 ML?

No other NADAC-published product currently shares the active ingredient and strength of INVEGA TRINZA 273 MG/0.88 ML in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures INVEGA TRINZA 273 MG/0.88 ML?

INVEGA TRINZA 273 MG/0.88 ML (NDC 50458060601) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.